— Know what they know.
Not Investment Advice

IRME OTC

IR-Med Inc.
1W: +0.0% 1M: +0.0% 3M: -70.0% YTD: -94.8% 1Y: -95.6% 3Y: -99.6% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 52 · $162202 mcap · 29M float · 0.0003% daily turnover · Short 66% of daily vol

Balance Sheet Trends

Total Assets
$251K -74.9% ▼
5Y CAGR: -0.3%
Total Liabilities
$545K -14.0% ▼
5Y CAGR: +10.2%
Shareholders Equity
-$294K -180.5% ▼
Cash & Investments
$129K -83.2% ▼
5Y CAGR: -11.3%
Total Debt
$157K -21.5% ▼
5Y CAGR: +1.3%
Net Debt
$28K +104.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$2M$3M$3M$767K$129K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2M$3M$3M$767K$129K
Net Receivables$0$66K$55K$81K$54K
Inventory$0$0$12K-$81$0
Other Current Assets$0$0$0$81K$0
Total Current Assets$2M$3M$3M$848K$205K
Property, Plant & Equip.$6K$31K$226K$140K$35K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$30K-$1M-$2M$11K
Total Non-Current Assets$6K$61K$237K$151K$46K
Total Assets$2M$3M$3M$999K$251K
— Liabilities —
Accounts Payable$25K$58K$65K$62K$58K
Short-Term Debt$0$0$162K$39K$157K
Deferred Revenue$0$0$50K$50K$0
Other Current Liabilities$462K$208K$436K$322K$19K
Total Current Liabilities$523K$395K$662K$473K$545K
Long-Term Debt$166K$177K$0$161K$0
Other Non-Current Liab.$0$0$0$19K$0
Total Non-Current Liabilities$166K$177K$40K$161K$0
Total Liabilities$689K$572K$702K$634K$545K
— Equity —
Common Stock$54K$64K$68K$69K$70K
Retained Earnings-$1M-$5M-$10M-$15M-$17M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$1M$2M$3M$365K-$294K
Total Liabilities & Equity$2M$3M$3M$999K$251K
— Key Metrics —
Total Debt$166K$177K$276K$200K$157K
Net Debt-$2M-$3M-$3M-$567K$28K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms